Variant report

Variant	nsv824447
Chromosome Location	chr8:1044232-1056953
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:17)
CpG islands
(count:1891)
Chromatin interactive
region (count:1)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:17 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr8:1055977-1056033	GM10248	blood:	n/a	n/a
2	EGR1	chr8:1048458-1048712	K562	blood:	n/a	n/a
3	EGR1	chr8:1048717-1048925	K562	blood:	n/a	n/a
4	MYC	chr8:1051760-1051807	MCF-7	breast:	n/a	n/a
5	MYC	chr8:1051763-1051770	MCF-7	breast:	n/a	n/a
6	MYC	chr8:1051665-1051913	MCF-7	breast:	n/a	n/a
7	POLR2A	chr8:1050922-1051364	H1-neurons	neurons:	n/a	n/a
8	POLR2A	chr8:1045057-1045106	MCF-7	breast:	n/a	n/a
9	POLR2A	chr8:1051677-1051712	MCF-7	breast:	n/a	n/a
10	POLR2A	chr8:1044318-1044799	H1-neurons	neurons:	n/a	n/a
11	POLR2A	chr8:1044328-1044809	H1-neurons	neurons:	n/a	n/a
12	POLR2A	chr8:1051680-1051842	MCF-7	breast:	n/a	n/a
13	POLR2A	chr8:1051724-1051882	MCF-7	breast:	n/a	n/a
14	POLR2A	chr8:1050334-1050474	GM12878	blood:	n/a	n/a
15	REST	chr8:1050972-1051440	H1-neurons	neurons:	n/a	n/a
16	REST	chr8:1044312-1044877	H1-neurons	neurons:	n/a	n/a
17	REST	chr8:1043980-1045109	H1-neurons	neurons:	n/a	chr8:1044948-1044957

(count:1891 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:1048844-1048894	HCT-116	colon:	n/a
2	chr8:1051703-1051753	IMR90	lung:	fetal
3	chr8:1046358-1046408	PrEC	prostate:	n/a
4	chr8:1049477-1049527	Hela-S3	cervix:	n/a
5	chr8:1050972-1051022	Hepatocyte	liver:	n/a
6	chr8:1048486-1048536	SKMC	muscle:	n/a
7	chr8:1048844-1048894	HMEC	breast:	n/a
8	chr8:1050972-1051022	HL-60	blood:	n/a
9	chr8:1051510-1051560	Jurkat	blood:	n/a
10	chr8:1049477-1049527	NHBE	bronchial:	n/a
11	chr8:1049394-1049444	SK-N-MC	brain:	n/a
12	chr8:1048765-1048815	AG10803	skin:	n/a
13	chr8:1048765-1048815	NH-A	brain:	n/a
14	chr8:1049394-1049444	HPAEpiC	pulmonary alveolar:	n/a
15	chr8:1048486-1048536	HEK293	kidney:	embryo
16	chr8:1053508-1053558	ovcar-3	ovarian:	n/a
17	chr8:1047734-1047784	GM12878	blood:	n/a
18	chr8:1051703-1051753	ovcar-3	ovarian:	n/a
19	chr8:1048486-1048536	Jurkat	blood:	n/a
20	chr8:1046622-1046672	HPAEpiC	pulmonary alveolar:	n/a
21	chr8:1051728-1051778	U87	brain:	n/a
22	chr8:1053480-1053530	HIPEpiC	eye:	n/a
23	chr8:1046358-1046408	A549	lung:	n/a
24	chr8:1051703-1051753	AG09319	gingival:	n/a
25	chr8:1051728-1051778	H1-hESC	embryonic stem cell:	embryo
26	chr8:1051728-1051778	SK-N-MC	brain:	n/a
27	chr8:1054065-1054115	LNCaP	prostate:	n/a
28	chr8:1054487-1054537	Hela-S3	cervix:	n/a
29	chr8:1054048-1054098	HPAEpiC	pulmonary alveolar:	n/a
30	chr8:1048135-1048185	Jurkat	blood:	n/a
31	chr8:1054065-1054115	Jurkat	blood:	n/a
32	chr8:1048112-1048162	Hela-S3	cervix:	n/a
33	chr8:1053157-1053207	NH-A	brain:	n/a
34	chr8:1051510-1051560	ovcar-3	ovarian:	n/a
35	chr8:1048765-1048815	BJ	skin:	n/a
36	chr8:1049901-1049951	AG09309	skin:	n/a
37	chr8:1048765-1048815	GM12878	blood:	n/a
38	chr8:1049215-1049265	HCT-116	colon:	n/a
39	chr8:1050972-1051022	BJ	skin:	n/a
40	chr8:1053157-1053207	GM12892	blood:	n/a
41	chr8:1049901-1049951	K562	blood:	n/a
42	chr8:1053439-1053489	SKMC	muscle:	n/a
43	chr8:1051585-1051635	SK-N-SH_RA	brain:	n/a
44	chr8:1054786-1054836	HCM	heart:	n/a
45	chr8:1054899-1054949	ProgFib	skin:	n/a
46	chr8:1050972-1051022	PFSK-1	brain:	n/a
47	chr8:1049215-1049265	A549	lung:	n/a
48	chr8:1048844-1048894	GM12891	blood:	n/a
49	chr8:1050972-1051022	Hela-S3	cervix:	n/a
50	chr8:1053157-1053207	Hepatocyte	liver:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr8:1055778..1058022-chr8:1059688..1062614,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FBXO25-5	chr8:1054882-1055066	ENSG00000254269
2	lnc-FBXO25-5	chr8:1054883-1055066	ENSG00000237647.4

No data

Variant related genes	Relation type
ENSG00000254269	TF binding region
ENSG00000254269	CpG island

Extended variants
information (count: 772 )
Associated
traits (count: 115 )

Variant overlapped rSNPs/rCNVs (count:772 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs138870483	chr8:1044236-1044237	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs183827463	chr8:1044246-1044247	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs541929777	chr8:1044248-1044249	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs112658482	chr8:1044341-1044342	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs561750991	chr8:1044342-1044343	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs530395093	chr8:1044364-1044365	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs188868400	chr8:1044368-1044369	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs564581744	chr8:1044370-1044371	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs533355055	chr8:1044395-1044396	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs546839534	chr8:1044418-1044419	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs566715019	chr8:1044425-1044426	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs529384155	chr8:1044435-1044436	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs112511079	chr8:1044442-1044443	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs549188031	chr8:1044459-1044460	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs537392404	chr8:1044475-1044476	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs61495115	chr8:1044487-1044488	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs537818273	chr8:1044518-1044519	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs77636367	chr8:1044519-1044520	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs192588095	chr8:1044537-1044538	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs374592624	chr8:1044543-1044544	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs113601100	chr8:1044565-1044566	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs573051896	chr8:1044569-1044570	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs148133599	chr8:1044591-1044592	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs182089810	chr8:1044592-1044593	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs548826044	chr8:1044612-1044613	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs142025351	chr8:1044613-1044614	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs186769825	chr8:1044650-1044651	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs191582843	chr8:1044658-1044659	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs577959948	chr8:1044665-1044666	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs540511899	chr8:1044667-1044668	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs534868200	chr8:1044679-1044680	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs111759971	chr8:1044689-1044690	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs549472511	chr8:1044692-1044693	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs147323976	chr8:1044698-1044699	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs184144408	chr8:1044710-1044711	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs140348710	chr8:1044722-1044723	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs188329569	chr8:1044766-1044767	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs112873922	chr8:1044774-1044775	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs546887229	chr8:1044786-1044787	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs114489189	chr8:1044827-1044828	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs147342315	chr8:1044842-1044843	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs555442439	chr8:1044854-1044855	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs575290012	chr8:1044862-1044863	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs375025908	chr8:1044863-1044864	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs149897821	chr8:1044871-1044872	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs574551985	chr8:1044872-1044873	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs540546671	chr8:1044899-1044900	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs145017346	chr8:1044914-1044915	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs193035168	chr8:1044917-1044918	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs116499148	chr8:1044948-1044949	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:115)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Schizophrenia	23813976	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Autism	20531469	CNVD
Breast cancer	20932292	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:50 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1040800-1044800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
2	chr8:1041600-1045800	Enhancers	Fetal Brain Male	brain
3	chr8:1043600-1045400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
4	chr8:1043800-1044400	Enhancers	Brain Germinal Matrix	brain
5	chr8:1043800-1045200	Enhancers	Brain Inferior Temporal Lobe	brain
6	chr8:1044000-1044600	Enhancers	Brain Cingulate Gyrus	brain
7	chr8:1044000-1044800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr8:1044000-1045000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr8:1044000-1045000	Flanking Active TSS	Fetal Brain Female	brain
10	chr8:1044000-1045400	Enhancers	Brain Angular Gyrus	brain
11	chr8:1044000-1046200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr8:1044200-1045400	Weak transcription	Fetal Thymus	thymus
13	chr8:1044400-1045000	Enhancers	Cortex derived primary cultured neurospheres	brain
14	chr8:1044400-1045000	Flanking Active TSS	Brain Germinal Matrix	brain
15	chr8:1044600-1044800	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr8:1044600-1044800	Flanking Active TSS	Brain Cingulate Gyrus	brain
17	chr8:1044600-1045000	Flanking Active TSS	Brain Anterior Caudate	brain
18	chr8:1044600-1045200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
19	chr8:1044800-1045000	Enhancers	Brain Cingulate Gyrus	brain
20	chr8:1044800-1045200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr8:1044800-1045200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
22	chr8:1044800-1045200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr8:1044800-1046000	Weak transcription	HUES48 Cell Line	embryonic stem cell
24	chr8:1045000-1045200	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr8:1045000-1045200	Enhancers	Brain Anterior Caudate	brain
26	chr8:1045000-1045200	Flanking Active TSS	Brain Cingulate Gyrus	brain
27	chr8:1045000-1045200	Enhancers	Gastric	stomach
28	chr8:1045000-1045600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr8:1045000-1046400	Enhancers	Brain Germinal Matrix	brain
30	chr8:1045000-1046400	Enhancers	Fetal Brain Female	brain
31	chr8:1045200-1045600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
32	chr8:1045200-1046200	Weak transcription	Gastric	stomach
33	chr8:1045400-1045800	Enhancers	Fetal Thymus	thymus
34	chr8:1045600-1046200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr8:1045800-1046400	Enhancers	Fetal Lung	lung
36	chr8:1045800-1050400	Weak transcription	Fetal Brain Male	brain
37	chr8:1046000-1046400	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr8:1046000-1046400	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr8:1046200-1046800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr8:1046200-1047400	Enhancers	Gastric	stomach
41	chr8:1046400-1047600	Weak transcription	Fetal Lung	lung
42	chr8:1046400-1051600	Weak transcription	Brain Germinal Matrix	brain
43	chr8:1046800-1050800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr8:1047600-1048200	Enhancers	Fetal Lung	lung
45	chr8:1047800-1048000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
46	chr8:1049400-1049800	Enhancers	Brain Hippocampus Middle	brain
47	chr8:1050400-1051600	Enhancers	Fetal Brain Male	brain
48	chr8:1054200-1054800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr8:1054800-1055200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr8:1055200-1057200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links